Pfizer to further reduce stake in Haleon, offers to sell 540 million share
Separately, Haleon will also buy around £230 million worth of its shares from Pfizer at the price set in the share offering, the statement shows. The offering and buyback together would reduce Pfizer’s stake in the maker of Sensodyne toothpaste to 16.2% from 22.6%.
Pfizer's stake sale in British consumer healthcare company Haleon has been upsized by 100 million shares to 640 million ...
Following a similar move in March, Pfizer is offloading another tranche of Haleon shares. | Pfizer has sold 640 million ...
Haleon, a global leader in consumer health, today announced the appointment of Christine Jakovcic as General Manager, Haleon ...
Pfizer said, further to the Launch Announcement on 30 September 2024, it has sold 640 million ordinary shares in Haleon plc, at a ...
Pfizer Inc. plans to sell 540 million worth of shares in Haleon Plc, as it pares back its holding in the UK consumer health ...
DRL's Swiss subsidiary completed the acquisition through the purchase of shares of Northstar Switzerland SARL, a Haleon group ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback